Lantheus Holdings, Inc. (NASDAQ: LNTH)

This lawsuit is for anyone who acquired securities in Lantheus Holdings, Inc. (NASDAQ: LNTH) from February 26, 2025 through August 5, 2025.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by understating the degree to which competition would affect the Company’s ability to maintain the price of the Company’s key Radiopharmaceutical Oncology product, Pylarify.

On May 7, 2025, Lantheus released its first quarter 2025 financial results, missing consensus estimates, specifically with the Company’s key Radiopharmaceutical Oncology product, Pylarify. The Company disclosed that Pylarify sales had decreased year-over-year due to an alleged “temporal competitive disruption.” Additionally, the Company reduced its full-year guidance. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume. Then, on August 6, 2025, Lantheus released its second quarter 2025 financial results, once again missing estimates and significantly reduced growth expectations for Pylarify, due to ongoing completion impacting pricing dynamics. The Company further slashed its full-year guidance. On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Lantheus Holdings, Inc. (NASDAQ: LNTH) from February 26, 2025 through August 5, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.